• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Differences in pain management between hematologists and hospitalists caring for patients with sickle cell disease hospitalized for vasoocclusive crisis.血液病学家和医院内科医生在镰状细胞病血管阻塞性危象住院患者疼痛管理方面的差异。
Clin J Pain. 2014 Mar;30(3):266-8. doi: 10.1097/AJP.0b013e318295ec04.
2
Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.成人镰状细胞病血管闭塞性危象患者肠外阿片类药物剂量的比较
J Pain Palliat Care Pharmacother. 2018 Dec;32(4):201-207. doi: 10.1080/15360288.2019.1577938. Epub 2019 Mar 21.
3
Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.采用护理路径对镰状细胞病患者的血管闭塞性疼痛危象进行住院医师管理。
Hosp Pract (1995). 2014 Apr;42(2):70-6. doi: 10.3810/hp.2014.04.1105.
4
Comparison of Hospital Resource Use and Outcomes Among Hospitalists, Primary Care Physicians, and Other Generalists.比较医院医生、初级保健医生和其他通科医生的医院资源利用和结局。
JAMA Intern Med. 2017 Dec 1;177(12):1781-1787. doi: 10.1001/jamainternmed.2017.5824.
5
Letter to Editor: Comparison of Outcomes for Adult Inpatients With Sickle Cell Disease Cared for by Hospitalists Versus Hematologists.
Am J Med Qual. 2020 Jul/Aug;35(4):361. doi: 10.1177/1062860619892060. Epub 2019 Dec 20.
6
Patient-Controlled Analgesia vs Intravenous Push Hydromorphone for Pain Management of Vaso-Occlusive Crisis Associated With Sickle Cell Disease.患者自控镇痛与静脉推注氢吗啡酮治疗镰状细胞病相关血管阻塞性危象的疼痛管理。
J Pain Palliat Care Pharmacother. 2023 Jun;37(2):116-122. doi: 10.1080/15360288.2023.2167035. Epub 2023 Jan 26.
7
Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.芬太尼口腔崩解片:镰状细胞病严重血管闭塞性危象早期管理中的新型突破性止痛药物。
Pain Pract. 2016 Jul;16(6):680-7. doi: 10.1111/papr.12313. Epub 2015 May 26.
8
Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.镰状细胞病血管闭塞性危象期间患者自控镇痛与吗啡持续输注的随机对照试验
Am J Hematol. 2007 Nov;82(11):955-60. doi: 10.1002/ajh.20944.
9
Adverse Events and Patient Outcomes Among Hospitalized Children Cared for by General Pediatricians vs Hospitalists.儿科医生与医院医师对住院患儿的治疗效果及不良事件的比较。
JAMA Netw Open. 2018 Dec 7;1(8):e185658. doi: 10.1001/jamanetworkopen.2018.5658.
10
Patient-controlled Analgesia For Vaso-Occlusive Crisis: A Cohort Study.患者自控镇痛用于血管阻塞性危象:一项队列研究。
Clin J Pain. 2019 Aug;35(8):686-690. doi: 10.1097/AJP.0000000000000726.

引用本文的文献

1
Vaso-occlusive crisis in sickle cell disease: current paradigm on pain management.镰状细胞病的血管闭塞性危机:疼痛管理的当前范式
J Pain Res. 2018 Dec 11;11:3141-3150. doi: 10.2147/JPR.S185582. eCollection 2018.
2
Management of Sickle Cell Disease Super Utilizers.镰状细胞病超级使用者的管理
West J Emerg Med. 2017 Feb;18(2):251-252. doi: 10.5811/westjem.2016.12.33224. Epub 2017 Jan 30.
3
Derivation and preliminary validation of a risk score to predict 30-day ED revisits for sickle cell pain.用于预测镰状细胞疼痛30天急诊科再就诊风险评分的推导与初步验证
Am J Emerg Med. 2015 Oct;33(10):1396-401. doi: 10.1016/j.ajem.2015.07.015. Epub 2015 Jul 17.

本文引用的文献

1
Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.执行摘要:《抗栓治疗与血栓形成预防》第9版:美国胸科医师学会循证临床实践指南。
Chest. 2012 Feb;141(2 Suppl):7S-47S. doi: 10.1378/chest.1412S3.
2
Inpatient management of sickle cell pain: a 'snapshot' of current practice.镰状细胞疼痛的住院管理:当前实践的“快照”。
Am J Hematol. 2012 Mar;87(3):333-6. doi: 10.1002/ajh.22265. Epub 2012 Jan 9.
3
Frequently asked questions by hospitalists managing pain in adults with sickle cell disease. 血液病专家管理镰状细胞病成人疼痛的常见问题解答。
J Hosp Med. 2011 May;6(5):297-303. doi: 10.1002/jhm.933.
4
The DEDUCE Guided Query tool: providing simplified access to clinical data for research and quality improvement.DEDUCE 引导查询工具:为研究和质量改进提供简化的临床数据访问。
J Biomed Inform. 2011 Apr;44(2):266-76. doi: 10.1016/j.jbi.2010.11.008. Epub 2010 Dec 2.
5
Acute care utilization and rehospitalizations for sickle cell disease.镰状细胞病的急性护理利用和再住院情况。
JAMA. 2010 Apr 7;303(13):1288-94. doi: 10.1001/jama.2010.378.
6
Pain management in sickle cell disease: palliative care begins at birth?镰状细胞病的疼痛管理:姑息治疗从出生就开始吗?
Hematology Am Soc Hematol Educ Program. 2008:466-74. doi: 10.1182/asheducation-2008.1.466.
7
Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance.成人镰状细胞急性疼痛发作的医院再入院:频率、病因及预后意义。
Am J Hematol. 2005 May;79(1):17-25. doi: 10.1002/ajh.20336.
8
Survival of children with sickle cell disease.镰状细胞病患儿的生存情况。
Blood. 2004 Jun 1;103(11):4023-7. doi: 10.1182/blood-2003-11-3758. Epub 2004 Feb 5.
9
A comparison of two regimens of patient-controlled analgesia for children with sickle cell disease.镰状细胞病患儿两种患者自控镇痛方案的比较。
J Pediatr Nurs. 1998 Feb;13(1):15-9. doi: 10.1016/S0882-5963(98)80064-X.

血液病学家和医院内科医生在镰状细胞病血管阻塞性危象住院患者疼痛管理方面的差异。

Differences in pain management between hematologists and hospitalists caring for patients with sickle cell disease hospitalized for vasoocclusive crisis.

机构信息

*Department of Pediatric Hematology/Oncology †Division of Hematology ‡Department of Pediatrics §Division of Oncology ∥Department of Hospital Medicine, Duke University Medical Center, Durham, NC.

出版信息

Clin J Pain. 2014 Mar;30(3):266-8. doi: 10.1097/AJP.0b013e318295ec04.

DOI:10.1097/AJP.0b013e318295ec04
PMID:23669451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3779519/
Abstract

OBJECTIVES

Sickle cell disease (SCD) is a chronic disease characterized by multiple vaso-occlusive complications and is increasingly cared for by hospitalists. The purpose of this study is to examine differences in pain management between hematologists and hospitalists.

METHODS

We performed a single-institution, retrospective review of pain management patterns and outcomes in adult SCD patients hospitalized for vaso-occlusive crisis.

RESULTS

Over 26 months, we found a total of 298 patients (120 cared for by the hematologists and 178 by hospitalists), with a mean age of 32 (range 19-58). Patients cared for by hospitalists had a lower total number of hours on a patient controlled analgesia (PCA) device (171 vs. 212 hours, P=0.11). Hospitalists also were significantly more likely to utilize demand only PCA (42% vs. 23%, P=0.002) and had a significantly lower rate of using both continuous and demand PCA (54% vs. 67%, P=0.04). In addition, patients cared for by hospitalists had a significantly shorter hospitalization (8.4 days) compared to hematologists (10 days, P=0.04) with a non-significant difference in 7 and 30 day readmission rates (7.2% vs. 6.7% and 40% vs. 35% respectively).

CONCLUSION

We found patients cared for by hospitalists more frequently utilized home oral pain medication during admission, had shorter lengths of hospitalization, and did not have a significant increase in readmission rates.

摘要

目的

镰状细胞病(SCD)是一种慢性疾病,其特征为多种血管阻塞性并发症,并越来越多地由医院医生进行治疗。本研究的目的是研究血液病医生和医院医生在疼痛管理方面的差异。

方法

我们对因血管阻塞性危象住院的成年 SCD 患者的疼痛管理模式和结局进行了单机构回顾性研究。

结果

在 26 个月期间,我们共发现 298 例患者(120 例由血液病医生治疗,178 例由医院医生治疗),平均年龄为 32 岁(19-58 岁)。由医院医生治疗的患者使用患者自控镇痛(PCA)设备的总时间明显较短(171 小时与 212 小时,P=0.11)。医院医生更倾向于使用仅按需 PCA(42%比 23%,P=0.002),而使用连续和按需 PCA 的比例明显较低(54%比 67%,P=0.04)。此外,与血液病医生相比,由医院医生治疗的患者的住院时间明显缩短(8.4 天与 10 天,P=0.04),7 天和 30 天再入院率差异无统计学意义(分别为 7.2%比 6.7%和 40%比 35%)。

结论

我们发现,由医院医生治疗的患者在住院期间更频繁地使用家庭口服止痛药,住院时间更短,再入院率没有显著增加。